Videos
Frontline Treatment Strategies in EGFR-Mutant NSCLC
Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer.
Therapeutic Management of Immune Thrombocytopenia
Therapeutic Management of Immune Thrombocytopenia
Treating High-Risk Multiple Myeloma
Ahmad Tarhini, MD, PhD, director of the Melanoma and Skin Cancer Program and Immune-Oncology Research at the Cleveland Clinic Taussig Cancer Institute, discusses 3 recent trials that are changing the adjuvant treatment landscape of melanoma. The treatments presented in these trials have less toxicities overall and less impact on the quality of life, according to Tarhini.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Real-World Data Link Higher Hemoglobin to Improved Survival in MDS
2
Early Relapse Guides Use of CAR T Vs Other Options in LBCL
3
Breast Cancer Test Using Proteomic Profiling and AI Demonstrates High Performance
4
Dr Mayer on Giredestrant's Success in Early Breast Cancer
5
